Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Olli Halminen"'
Autor:
Juha Hartikainen, Jukka Putaala, Jari Haukka, Juhani K E Airaksinen, Pirjo Mustonen, Konsta Teppo, Olli Halminen, Aapo Aro, Mika Lehto, Elis Kouki, Birgitta Salmela, Mika Linna
Publikováno v:
BMJ Open, Vol 14, Iss 9 (2024)
Objectives Atrial fibrillation (AF) is associated with increased mortality. Previous studies have reported conflicting results in temporal trends of mortality after AF diagnosis. We aim to address this disparity by investigating the 1-year mortality
Externí odkaz:
https://doaj.org/article/7d39637aac704aaea05f21eb303f72c0
Autor:
Antti Lappalainen, Juha E.K. Hartikainen, Konsta Teppo, Olli Halminen, Aapo L. Aro, Rasmus Siponen, Janne Virrankorpi, Annukka Marjamaa, Birgitta Salmela, Jukka Putaala, Pirjo Mustonen, Miika Linna, Jari Haukka, K.E. Juhani Airaksinen, Mika Lehto
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 55, Iss , Pp 101541- (2024)
Background: Catheter ablation is a well-established treatment to prevent atrial fibrillation (AF) and atrial flutter (AFL) recurrences and to relieve symptoms, whereas pacemaker implantation and atrioventricular node (AVN) ablation is used for rate c
Externí odkaz:
https://doaj.org/article/075bf0b55a8f4b88a75e7342accdd328
Autor:
Mika Lehto, Alex Luojus, Olli Halminen, Jari Haukka, Jukka Putaala, Miika Linna, Pirjo Mustonen, Janne Kinnunen, Ossi Lehtonen, Konsta Teppo, Paula Tiili, Elis Kouki, Saga Itäinen-Strömberg, Mikko Niemi, Aapo L. Aro, Juha Hartikainen, K. E. Juhani Airaksinen
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
Background Little is known how individual time-in-therapeutic-range (TTR) impacts the effectiveness and safety of warfarin therapy compared to direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF).Objective To compare the effec
Externí odkaz:
https://doaj.org/article/73fe543e868b49939f16146669005f27
Autor:
Konsta Teppo, K. E. Juhani Airaksinen, Fausto Biancari, Jussi Jaakkola, Olli Halminen, Miika Linna, Jari Haukka, Jukka Putaala, Pirjo Mustonen, Janne Kinnunen, Alex Luojus, Juha Hartikainen, Aapo L. Aro, Mika Lehto
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 9 (2023)
Background Patients with aortic stenosis (AS) have been underrepresented in the trials evaluating direct oral anticoagulants (DOACs) in atrial fibrillation (AF). We aimed to assess whether AS impacts outcomes in patients with AF and estimate the effe
Externí odkaz:
https://doaj.org/article/75c6c24d51d44e93a782a744022c9251
Autor:
Lars Frost, Olli Halminen, Mika Lehto, K E. Juhani Airaksinen, Tomas Andersson, Per Wändell, Martin Holzmann, Pia Cordsen, Nicklas Vinter, Søren Paaske Johnsen
Publikováno v:
TH Open, Vol 07, Iss 02, Pp e133-e142 (2023)
Background Geographical mapping of variations in the treatment and outcomes of a disease is a valuable tool for identifying inequity. We examined international and intranational variations in initiating oral anticoagulation (OAC) therapy and clinical
Externí odkaz:
https://doaj.org/article/ca44bb21f1114e47b9197e3440700c03
Autor:
Konsta Teppo, Jussi Jaakkola, Fausto Biancari, Olli Halminen, Miika Linna, Jukka Putaala, Pirjo Mustonen, Janne Kinnunen, Santeri Jolkkonen, Mikko Niemi, Juha Hartikainen, K. E. Juhani Airaksinen, Mika Lehto
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 43, Iss , Pp 101131- (2022)
Background: Low socioeconomic status has been associated with higher risk of ischemic stroke and death in patients with atrial fibrillation (AF). However, whether socioeconomic status affects risk of bleeding events is unknown. We assessed the hypoth
Externí odkaz:
https://doaj.org/article/210e29e3622649f5ba6a9597d74caae1
Autor:
Juha Hartikainen, Jukka Putaala, Jari Haukka, Juhani K E Airaksinen, Pirjo Mustonen, Miika Linna, Olli Halminen, Janne Kinnunen, Aapo Aro, Mika Lehto, Alex Luojus, Saga Itäinen-Strömberg, Elis Kouki, Jussi Niiranen, Paula Tiili
Publikováno v:
Open Heart, Vol 9, Iss 2 (2022)
Objective Atrial fibrillation (AF) is a worldwide healthcare challenge owing to population ageing. In this study, we assessed the current trends in the incidence and prevalence of AF for the first time in an unselected, nationwide population.Methods
Externí odkaz:
https://doaj.org/article/4a47d82e839d4f52a53a0a48174770eb
Autor:
Juha Hartikainen, Jukka Putaala, Jari Haukka, Fausto Biancari, Pirjo Mustonen, Miika Linna, Konsta Teppo, Jussi Jaakkola, Olli Halminen, Janne Kinnunen, Mika Lehto, Alex Luojus, Saga Itäinen-Strömberg, Tero Penttilä, Mikko Niemi, KE Juhani Airaksinen
Publikováno v:
BMJ Open, Vol 12, Iss 8 (2022)
Objectives Mental health conditions (MHCs) have been associated with undertreatment of unrelated medical conditions, but whether patients with MHCs face disparities in receiving rhythm control therapies for atrial fibrillation (AF) is currently unkno
Externí odkaz:
https://doaj.org/article/cf6f94daeffd4a9296e9bf5959d9cf25
Autor:
Konsta Teppo, Jussi Jaakkola, Fausto Biancari, Olli Halminen, Miika Linna, Jari Haukka, Jukka Putaala, Pirjo Mustonen, Janne Kinnunen, Alex Luojus, Saga Itäinen-Strömberg, Juha Hartikainen, Aapo L. Aro, K.E. Juhani Airaksinen, Mika Lehto
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 41, Iss , Pp 101070- (2022)
Background: In patients with atrial fibrillation (AF), socioeconomic disparities have been reported in the use of oral anticoagulant therapy and outcomes, but whether income also affects the utilization of antiarrhythmic therapies (AATs) for rhythm c
Externí odkaz:
https://doaj.org/article/553cc02bdda24d92886b247edcc17575
Autor:
Konsta Teppo, Jussi Jaakkola, Fausto Biancari, Olli Halminen, Miika Linna, Jari Haukka, Jukka Putaala, Paula Tiili, Ossi Lehtonen, Mikko Niemi, Pirjo Mustonen, Janne Kinnunen, Juha Hartikainen, K. E. Juhani Airaksinen, Mika Lehto
Publikováno v:
Pharmacology Research & Perspectives, Vol 10, Iss 3, Pp n/a-n/a (2022)
Abstract Low socioeconomic status has been associated with poor outcomes in patients with atrial fibrillation (AF). However, little is known about socioeconomic disparities in adherence to stroke prevention with direct oral anticoagulants (DOACs). We
Externí odkaz:
https://doaj.org/article/36206cd34b25456785526f3ad97daad7